Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer

Journal of Clinical Oncology

Volumn 26, Issue 1, 2008, Pages 32-36

  Susswein, Lisa R ^a   Skrzynia, Cécile ^a   Lange, Leslie A ^a   Booker, Jessica K ^a   Graham III, Mark L ^a   Evans, James P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC PROCEDURES; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RISK ASSESSMENT;

ADULT; AFRICAN AMERICANS; ATTITUDE TO HEALTH; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MIDDLE AGED; MUTATION; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 37849013468     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.6377     Document Type: Article

References (22)

1. Hartmann LC, Sellers TA, Schaid DJ, et al: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633-1637, 2001
2. Gronwald J, Tung N, Foulkes WD, et al: Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update. Int J Cancer 118: 2281-2284, 2006
3. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004
4. Weitzel JN, McCaffrey SM, Nedelcu R, et al: Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 138:1323-1328, 2003
5. Haffty BG, Harrold E, Khan AJ, et al: Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359:1471-1477, 2002
6. Pierce LJ, Levin AM, Rebbeck TR, et al: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 24:2437-2443, 2006
7. Hall MJ, Olopade OI: Disparities in genetic testing: Thinking outside the BRCA box. J Clin Oncol 24:2197-2203, 2006
8. Armstrong K, Micco E, Carney A, et al: Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:1729-1736, 2005
9. Lerman C, Hughes C, Benkendorf JL, et al: Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 8:361-367, 1999
10. Zimmerman RK, Tabbarah M, Nowalk MP, et al: Racial differences in beliefs about genetic screening among patients at inner-city neighborhood health centers. J Natl Med Assoc 98:370-377, 2006
11. Peters N, Rose A, Armstrong K: The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev 13:361-365, 2004
12. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, et al: Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 11:1579-1585, 2002
13. Halbert CH, Kessler LJ, Mitchell E: Genetic testing for inherited breast cancer risk in African Americans. Cancer Invest 23:285-295, 2005
14. Kinney AY, Croyle RT, Dudley WN, et al: Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with a BRCA1 mutation. Prev Med 33:543-551, 2001
15. Risch HA, McLaughlin JR, Cole DE, et al: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700-710, 2001
16. de Sanjose S, Leone M, Berez V, et al: Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population-based study. Int J Cancer 106:588-593, 2003
17. Berry DA, Iversen ES Jr, Gudbjartsson DF, et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712, 2002
18. Evans JP, Skrzynia C, Burke W: The complexities of predictive genetic testing. BMJ 322:1052-1056, 2001
19. Hughes C, Fasaye GA, LaSalle VH, et al: Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 51:107-114, 2003
20. Baldwin D: A model for describing low-income African American women's participation in breast and cervical cancer early detection and screening. ANS Adv Nurs Sci 19:27-42, 1996
21. Green MJ, Botkin JR: "Genetic exceptionalism" in medicine: Clarifying the differences between genetic and nongenetic tests. Ann Intern Med 138:571-575, 2003
22. Carey L, Perou C, Livasy C, et al: Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502, 2006